Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Sorrento Therapeutics Inc
About SRNE
Sorrento Therapeutics, Inc. is a clinical-stage, antibody-centric, biopharmaceutical company developing therapies to treat cancers and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. Sorrento Therapeutics segment is organized around Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate cancer therapeutics. The Scilex segment is largely organized around its non-opioid pain management operations. The Company’s immuno-oncology platforms, including key assets such as fully human antibodies (G-MAB library), clinical- stage immuno-cellular therapies (CAR-T, DAR-T), antibody-drug conjugates (ADCs) and clinical-stage oncolytic virus (Seprehvir). The Company is also developing potential antiviral therapies and vaccines against coronaviruses, including Abivertinib, COVI-AMG, COVISHIELD, COVI-MSC and COVIDROPS, and diagnostic test solutions, including COVITRACK and COVISTIX.
Find out what a historical investment in Sorrento Therapeutics Inc would be worth today using our SRNE stock calculator.
Market Capitalisation
$275.64K
Price-earnings ratio
-
Dividend yield
0.00%
Volume
277.96K
High today
$0.00
Low today
$0.00
Open price
$0.00
52-week high
$0.10
52-week low
$0.00
Ready to start your investing journey with Stake?
Open an accountHow do I buy SRNE shares in Australia?
Buying SRNE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Sorrento Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SRNE
What is the ticker symbol of Sorrento Therapeutics Inc?
The ticker symbol for Sorrento Therapeutics Inc is SRNE.
How much is one share of SRNE?
One share of SRNE is valued at $0.01 as of 20 May 2026.
What is the market capitalisation of Sorrento Therapeutics Inc SRNE?
As of 20 May 2026 Sorrento Therapeutics Inc has a market cap of $275.64K.
What is the 52-week high for Sorrento Therapeutics Inc stock?
The Sorrento Therapeutics Inc 52-week high stock price is $0.10.
What is the 52-week low for Sorrento Therapeutics Inc stock?
The Sorrento Therapeutics Inc 52-week low stock price is $0.00.
Can I buy SRNE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SRNE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SRNE on Stake
- Buy SRNE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SRNE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SRNE related stocks